SEC Form 15-12G filed by Theseus Pharmaceuticals Inc.
UNITED STATES
001-40869
|
Commission File Number
|
THESEUS PHARMACEUTICALS, INC.
|
(Exact name of registrant as specified in its charter)
|
314 Main Street
Cambridge, Massachusetts 02142
(857) 400-9491
|
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
|
Common Stock, $0.0001 par value per share
|
(Title of each class of securities covered by this Form)
|
None
|
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
|
Rule 12g-4(a)(1) |
☒
|
Rule 12g-4(a)(2) |
☐
|
Rule 12h-3(b)(1)(i) |
☒
|
Rule 12h-3(b)(1)(ii) Rule 15d-6 |
☐
|
Rule 15d-22(b) |
☐
|
Approximate number of holders of record as of the certification or notice date:
|
One
|
Date: February 26, 2024
|
THESEUS PHARMACEUTICALS, INC.
|
|
By:
|
/s/ Michael Hearne
|
|
Name: Michael Hearne
|
||
Title: Chief Financial Officer
|